EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients

Sherilyn Wong iD, Philip R Selby iD, Stephanie E Reuter iD

Pharmacology Research & Perspectives · 2024

DOI: 10.1002/prp2.1231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2024. Verfasst von Sherilyn Wong und 2 weiteren Autor:innen. Beteiligte Einrichtung: UniSA Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia. Hauptthemen laut MEDLINE: Vancomycin, Acute Kidney Injury, Anti-Bacterial Agents, Area Under Curve. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: SA Health, The Hospital Research Foundation, University of South Australia, Allied Health Research Collaboration grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An area‐under‐the‐curve (AUC 24 )‐based approach is recommended to guide vancomycin therapeutic drug monitoring (TDM), yet trough concentrations are still commonly used despite associated risks. A definitive toxicity target is lacking, which is important for hematology patients who have a higher risk of nephrotoxicity. The aims were to (1) assess the impact of trough‐based TDM on acute kidney injury (AKI) incidence, (2) establish a vancomycin nephrotoxicity threshold, and (3) evaluate the proportion of hematology patients achieving vancomycin therapeutic targets. Retrospective data was collected from 100 adult patients with a hematological malignancy or aplastic anemia who received vancomycin between April 2020 and January 2021. AKI occurrence was determined based on serum creatinine concentrations, and individual pharmacokinetic parameters were estimated using a Bayesian approach. Receiver operating characteristic (ROC) curve analysis was performed to assess the ability of pharmacokinetic indices to predict AKI occurrence. The proportion of patients who achieved target vancomycin exposure was evaluated based on an AUC 24 /MIC ≥400 and the determined toxicity threshold. The incidence of AKI was 37%. ROC curve analysis indicated a maximum AUC 24 of 644 mg.h/L over the treatment period was an important predictor of AKI. By Day 4 of treatment, 29% of treatment courses had supratherapeutic vancomycin exposure, with only 62% of courses achieving AUC 24 targets. The identified toxicity threshold supports an AUC 24 target range of 400–650 mg.h/L, assuming an MIC of 1 mg/L, to optimize vancomycin efficacy and minimize toxicity. This study highlights high rates of AKI in this population and emphasizes the importance of transitioning from trough‐based TDM to an AUC‐based approach to improve clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinAcute Kidney InjuryAnti-Bacterial AgentsArea Under CurveDrug MonitoringHematologic NeoplasmsHumansFemaleMaleMiddle AgedRetrospective StudiesAgedAdultAnemia, AplasticBayes TheoremCreatinineAged, 80 and overYoung AdultIncidenceMicrobial Sensitivity TestsROC Curve

Stichwörter der Autor:innen

hematologynephrotoxicitytherapeutic drug monitoringvancomycin

Substanzen

VancomycinAnti-Bacterial AgentsCreatinine

Autor:innen und Institutionen

  • UniSA Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.
  • School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia.
  • SA Pharmacy, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

ORCID-Profile: Sherilyn Wong, Philip R Selby, Stephanie E Reuter

Förderung

  • SA Health, The Hospital Research Foundation, University of South Australia
  • Allied Health Research Collaboration grant

Zitieren

APA

Wong, S., Selby, P. R., & Reuter, S. E. (2024). Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.1231

Vancouver

Wong S, Selby PR, Reuter SE. Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients. Pharmacology Research & Perspectives. 2024. doi:10.1002/prp2.1231

BibTeX
@article{Wong2024,
  author = {Wong, Sherilyn and Selby, Philip R and Reuter, Stephanie E},
  title = {Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients},
  journal = {Pharmacology Research & Perspectives},
  year = {2024},
  doi = {10.1002/prp2.1231}
}
Kostenlos starten →